Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KAT6A | Q92794 | 1/20 | 0.35 |
| ▸ | GRM5 | P41594 | 5/20 | 0.35 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.34 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.34 |
| ▸ | RAB9A | P51151 | 4/20 | 0.34 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.34 |
| ▸ | LMNA | P02545 | 3/20 | 0.34 |
| ▸ | MAPT | P10636 | 2/20 | 0.34 |
| ▸ | TP53 | P04637 | 2/20 | 0.34 |
| ▸ | PKM | P14618 | 2/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.34 |
| ▸ | HPGD | P15428 | 1/20 | 0.34 |
| ▸ | TSHR | P16473 | 1/20 | 0.34 |
| ▸ | KLF5 | Q13887 | 1/20 | 0.34 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.34 |
| ▸ | TLR4 | O00206 | 1/20 | 0.33 |
| ▸ | TLR2 | O60603 | 1/20 | 0.33 |
| ▸ | NPC1 | O15118 | 3/20 | 0.33 |
| ▸ | PIK3CA | P42336 | 1/20 | 0.33 |
| ▸ | PIK3CB | P42338 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12948982 | 0.87 | TLR4 (0.39) | KAT6AGRM5KDM4ETDP1RAB9A | |
| SCHEMBL24642252 | 0.86 | KMO (0.41) | GRM5KDM4ETDP1LMNAMAPT | |
| SCHEMBL24626925 | 0.83 | KDM4E (0.37) | KDM4ETDP1RAB9ASMN1; SMN2LMNA | |
| SCHEMBL24627008 | 0.81 | KDM4E (0.34) | KDM4ERAB9ASMN1; SMN2LMNAMAPT | |
| SCHEMBL17932826 | 0.80 | KDM4E (0.52) | KAT6AGRM5KDM4ETDP1RAB9A | |
| SCHEMBL25662211 | 0.79 | KDM4E (0.50) | KAT6AGRM5KDM4ETDP1RAB9A | |
| SCHEMBL17932281 | 0.79 | KDM4E (0.50) | KAT6AGRM5KDM4ETDP1RAB9A | |
| SCHEMBL19200791 | 0.79 | GRM5 (0.38) | KAT6AGRM5RAB9ALMNAMAPT | |
| SCHEMBL24626890 | 0.78 | GRM5 (0.36) | GRM5KDM4ERAB9ANPC1PIK3CA | |
| SCHEMBL24608650 | 0.78 | SGK1 (0.31) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230284471-A1 | LIGHT-EMITTING DEVICE AND ELECTRONIC APPARATUS INCLUDING THE SAME | SAMSUNG DISPLAY CO., LTD. (KR) | 2023-09-07 | — | — | US | disclosed |
| US-11690287-B2 | Organic light-emitting device and display apparatus including the same | SAMSUNG DISPLAY CO., LTD. (KR) | 2023-06-27 | — | — | US | disclosed |
| US-20200203621-A1 | ORGANIC LIGHT-EMITTING DEVICE AND DISPLAY APPARATUS INCLUDING THE SAME | SAMSUNG DISPLAY CO., LTD. (KR) | 2020-06-25 | — | — | US | disclosed |
| US-20200194694-A1 | ORGANOMETALLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME | SAMSUNG DISPLAY CO., LTD. (KR) | 2020-06-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11690287-B2 | Organic light-emitting device and display apparatus including the same | OR10J3, ALDH1A2, OCIAD1 | KAT6A 4716/4885GRM5 2462/4885KDM4E 3054/4885 |
| US-20200203621-A1 | ORGANIC LIGHT-EMITTING DEVICE AND DISPLAY APPARATUS INCLUDING THE SAME | OR10J3, ALDH1A2, OCIAD1 | KAT6A 4716/4885GRM5 2462/4885KDM4E 3054/4885 |
| US-20200194694-A1 | ORGANOMETALLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME | ORC3, OCIAD1, PPOX | KAT6A 2552/4885GRM5 2163/4885KDM4E 2236/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.